The stock market has risen over the last year, helping to break the 36,000 barrier.
IANS News Agency
The US stock market rebounded less than half of Friday's steep losses on Monday.
As investors assess the risk of the Omicron COVID-19 variant, the move higher comes.
Pfizer and Moderna are testing the effectiveness of their vaccines against Omicron.
The US stock market gained 1% on Monday, recovering some of the losses seen last Friday.
The 2% slide in stocks on Friday was caused by the identification of a new variant of the COVID-19 virus, Omicron, which is thought to be more contagious than previous versions.
Moderna and Pfizer said they are testing the effectiveness of current vaccines against the new strain, as well as new vaccines specifically targeting the Omicron variant. Moderna says that new vaccine formulas could be ready by early 2022, if needed.
The US indexes stood at 9:30 a.m. The hours are open on Monday.
Oil prices rebounded sharply in Monday trades after Friday's plunge, as concerns of potential country lockdowns to combat the Omicron variant seem less likely as early reports suggest only mild symptoms from the new variant.
Bill Ackman thinks that if Omicron symptoms are mild, it would be bullish for stocks and bearish for bonds.
Moderna's shares jumped 10% on Monday and continued their two-day gain to more than 30% as it revealed its vaccine plans for the Omicron variant. The 45% loss was caused by the surge that helped stem it.
The movie theater chain said it would give 86,000 NFTs to early ticket buyers of the upcoming Spider-Man movie.
The price of West Texas Intermediate crude oil went up as much as 6.74%. The price of oil's international benchmark rose as much as 5.65%.
The price of gold rose as much as 0.13%.
Business Insider has an original article.
